Ameritas Investment Partners’s MediciNova MNOV Stock Holding History

Ameritas Investment Partners’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,274	Closed	-$17K	–	3161
2021 Q1	$17K	Hold	3,274	–	–	﹤0.01%	2631
2020 Q4	$17K	Hold	3,274	–	–	﹤0.01%	2556
2020 Q3	$17K	Hold	3,274	–	–	﹤0.01%	2466
2020 Q2	$18K	Hold	3,274	–	–	﹤0.01%	2392
2020 Q1	$12K	Hold	3,274	–	–	﹤0.01%	2446
2019 Q4	$22K	Hold	3,274	–	–	﹤0.01%	2368
2019 Q3	$26K	Hold	3,274	–	–	﹤0.01%	2252
2019 Q2	$32K	Hold	3,274	–	–	﹤0.01%	2170
2019 Q1	$27K	Hold	3,274	–	–	﹤0.01%	2225
2018 Q4	$27K	Hold	3,274	–	–	﹤0.01%	2161
2018 Q3	$41K	Hold	3,274	–	–	﹤0.01%	2097
2018 Q2	$26K	Hold	3,274	–	–	﹤0.01%	2358
2018 Q1	$33K	Buy	3,274 +960	+41%	+$9.56K	﹤0.01%	2154
2017 Q4	$15K	Hold	2,314	–	–	﹤0.01%	2584
2017 Q3	$12K	Hold	2,314	–	–	﹤0.01%	2701
2017 Q2	$12K	Hold	2,314	–	–	﹤0.01%	2751
2017 Q1	$14K	Buy	+2,314	New	+$13.9K	﹤0.01%	2576

Other funds holding MNOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameritas Investment Partners's MNOV Position: Q2 2021 in Review

Ameritas Investment Partners sold out of MediciNova (MNOV) in Q2 2021, closing a stake of 3,274 shares — an estimated $17K sold.

Ameritas Investment Partners first reported a position in MNOV in Q1 2017 and held it in 17 quarters. The position peaked at $41K in Q3 2018. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2021.

Ameritas Investment Partners reported no remaining MediciNova position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 3,274 MediciNova shares in Q2 2021, an estimated $17K.
Ameritas Investment Partners first reported a position in MediciNova in Q1 2017 and held it in 17 quarters.
Ameritas Investment Partners's MediciNova position peaked at $41K in Q3 2018.
55 funds tracked by Wall St. Rank held MediciNova as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.